2023年中国重医美行业概览报告
Tou Bao Yan Jiu Yuan·2024-02-26 16:00

Investment Rating - The report indicates a positive investment outlook for the heavy medical aesthetic industry in China, with a projected compound annual growth rate (CAGR) of 9.9% from 2023 to 2027, increasing from 120.5 billion to 176 billion yuan [4][40]. Core Insights - The heavy medical aesthetic industry in China has shown robust growth, with market size increasing from 71.7 billion yuan in 2018 to 106.1 billion yuan in 2022, reflecting a CAGR of 10.3% [4][40]. - The demand for heavy medical aesthetics is driven by a combination of consumer spending and medical necessity, with the upper limit of demand growth determined by consumer behavior and the lower limit by medical factors [4][42]. - High-line cities are the primary consumer base, particularly women aged 20-30, who show a higher acceptance of medical aesthetic services [4][65]. Summary by Sections Overview of the Heavy Medical Aesthetic Industry - Heavy medical aesthetics, characterized by surgical procedures, aims to improve physical appearance through invasive methods, which can lead to significant recovery time and pain [4][16]. - The industry is categorized into four levels based on the complexity and risk of procedures, with typical services including rhinoplasty, breast augmentation, double eyelid surgery, and liposuction [4][18]. Market Size - The market size for heavy medical aesthetics in China is projected to grow from 120.5 billion yuan in 2023 to 176 billion yuan by 2027, with a CAGR of 9.9% [4][40]. - The demand for heavy medical aesthetics is influenced by the need for professional medical personnel and the associated risks of surgical procedures, which may limit growth compared to non-surgical options [4][35]. Industry Chain Analysis - The heavy medical aesthetic industry has a well-defined supply chain, with upstream suppliers providing surgical materials and instruments, midstream institutions offering medical services, and downstream platforms facilitating consumer access [4][54][55]. - The midstream segment is characterized by a mix of public and private medical institutions, with a fragmented market structure [4][55]. Competitive Landscape - The competitive landscape of the heavy medical aesthetic industry is evolving, with increasing regulatory scrutiny and a focus on service quality and consumer protection [4][30]. - Major players in the industry include established brands that are expanding their market presence through strategic acquisitions and partnerships [4][28].